The Impact of LY2189265 versus Insulin Glargine Both in Combination with Insulin Lispro for the Treatment to Target of Type 2 Diabetes Mellitus - GBDD
- Conditions
- Type 2 Diabetes MellitusMedDRA version: 12.1Level: LLTClassification code 10012601Term: Diabetes mellitus
- Registration Number
- EUCTR2010-019223-55-HU
- Lead Sponsor
- Eli Lilly & Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 837
Inclusion Criteria
See protocol for details.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
See protocol for details.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method